UA26204C2 - Спосіб запобігаhhя деградації кісткового протеза - Google Patents

Спосіб запобігаhhя деградації кісткового протеза

Info

Publication number
UA26204C2
UA26204C2 UA97020781A UA97020781A UA26204C2 UA 26204 C2 UA26204 C2 UA 26204C2 UA 97020781 A UA97020781 A UA 97020781A UA 97020781 A UA97020781 A UA 97020781A UA 26204 C2 UA26204 C2 UA 26204C2
Authority
UA
Ukraine
Prior art keywords
preventing degradation
bone prosthesis
bones
bases
organic
Prior art date
Application number
UA97020781A
Other languages
English (en)
Russian (ru)
Inventor
Джордж Джозеф КАЛЛІHАH
Original Assignee
Елі Ліллі Енд Компані
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Елі Ліллі Енд Компані, Эли Лилли Энд Компани filed Critical Елі Ліллі Енд Компані
Publication of UA26204C2 publication Critical patent/UA26204C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

У сучасній медичній практиці все більш широко використовуються різні протези, що кріпляться до кісток. Сполуки, корисні в способах по цьому винаходу, утворюють фармацевтично прийнятні кислотно-аддитивні солі і солі з основами для широкого кола органічних і неорганічних кислот і основ і включають фізіологічно прийнятні солі, які часто використовують у фармацевтичній хімії.
UA97020781A 1994-08-22 1995-08-21 Спосіб запобігаhhя деградації кісткового протеза UA26204C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/294,170 US5550123A (en) 1994-08-22 1994-08-22 Methods for inhibiting bone prosthesis degeneration
PCT/US1995/010616 WO1996005824A1 (en) 1994-08-22 1995-08-21 Methods for inhibiting bone prosthesis degeneration

Publications (1)

Publication Number Publication Date
UA26204C2 true UA26204C2 (uk) 1999-07-19

Family

ID=23132213

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97020781A UA26204C2 (uk) 1994-08-22 1995-08-21 Спосіб запобігаhhя деградації кісткового протеза

Country Status (18)

Country Link
US (1) US5550123A (uk)
EP (1) EP0769944A4 (uk)
JP (1) JPH10504576A (uk)
KR (1) KR970705384A (uk)
CN (1) CN1076968C (uk)
AU (1) AU701789B2 (uk)
CA (1) CA2198118A1 (uk)
CZ (1) CZ52097A3 (uk)
FI (1) FI970714A7 (uk)
HU (1) HUT76825A (uk)
IL (1) IL115021A (uk)
MX (1) MX9701334A (uk)
MY (1) MY132085A (uk)
NO (1) NO970786L (uk)
NZ (1) NZ292013A (uk)
UA (1) UA26204C2 (uk)
WO (1) WO1996005824A1 (uk)
ZA (1) ZA956990B (uk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CZ20013912A3 (cs) 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
WO2002003992A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating prosthesis-related bone degeneration
US9101978B2 (en) 2002-12-08 2015-08-11 Baker Hughes Incorporated Nanomatrix powder metal compact
US8403037B2 (en) 2009-12-08 2013-03-26 Baker Hughes Incorporated Dissolvable tool and method
US9079246B2 (en) 2009-12-08 2015-07-14 Baker Hughes Incorporated Method of making a nanomatrix powder metal compact
US9227243B2 (en) 2009-12-08 2016-01-05 Baker Hughes Incorporated Method of making a powder metal compact
US8776884B2 (en) 2010-08-09 2014-07-15 Baker Hughes Incorporated Formation treatment system and method
US9139928B2 (en) 2011-06-17 2015-09-22 Baker Hughes Incorporated Corrodible downhole article and method of removing the article from downhole environment
US9057242B2 (en) 2011-08-05 2015-06-16 Baker Hughes Incorporated Method of controlling corrosion rate in downhole article, and downhole article having controlled corrosion rate
US9033055B2 (en) 2011-08-17 2015-05-19 Baker Hughes Incorporated Selectively degradable passage restriction and method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US441868A (en) * 1890-12-02 Mechanical power
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
DE4122484A1 (de) * 1991-07-06 1993-01-07 Teves Gmbh Alfred Schaltungsanordnung zur erkennung von radsensordefekten
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5441964A (en) * 1993-10-15 1995-08-15 Eli Lilly And Company Methods for inhibiting bone loss using substituted benzothiophene

Also Published As

Publication number Publication date
HUT76825A (en) 1997-11-28
IL115021A0 (en) 1995-12-08
CA2198118A1 (en) 1996-02-29
EP0769944A1 (en) 1997-05-02
FI970714L (fi) 1997-02-20
CN1156406A (zh) 1997-08-06
US5550123A (en) 1996-08-27
CN1076968C (zh) 2002-01-02
MX9701334A (es) 1997-05-31
NO970786D0 (no) 1997-02-20
JPH10504576A (ja) 1998-05-06
KR970705384A (ko) 1997-10-09
CZ52097A3 (en) 1997-08-13
FI970714A0 (fi) 1997-02-20
NO970786L (no) 1997-02-20
AU701789B2 (en) 1999-02-04
EP0769944A4 (en) 1998-12-30
AU3369595A (en) 1996-03-14
ZA956990B (en) 1997-02-21
FI970714A7 (fi) 1997-02-20
WO1996005824A1 (en) 1996-02-29
MY132085A (en) 2007-09-28
NZ292013A (en) 2000-07-28
IL115021A (en) 2000-06-29

Similar Documents

Publication Publication Date Title
DK0998287T3 (da) Anvendelse af levobupivacain
ATE248599T1 (de) Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE3881303D1 (de) Prothese fuer den tibiateil eines kniegelenks.
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
PT881908E (pt) Utilizacao dos factores de crescimento de fibroblasto para estimular o crescimento osseo
SE8704248D0 (sv) Medical use
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
IT9041529A1 (it) Dispositivo per la correzione chirurgica dell'ametropia.
DK122391D0 (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
PT1017681E (pt) Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios
SE8704436D0 (sv) Anvendning av antisekretoriska substanser for nya indikationer
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
FI970715A0 (fi) Menetelmä luun parantamiseksi ja murtuman korjaamiseksi
ATE270863T1 (de) Gelenkimplantat und zugehörige hilfsinstrumente
ATE262538T1 (de) Lhrh-analoga zur behandlung der osteoporose
SU1318226A1 (ru) Способ пластики тазобедренного сустава
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
RU99106349A (ru) Способ лечения ортопедических и хирургических больных переартикулярным введением препарата
RU97114014A (ru) Способ предупреждения послеоперационных осложнений при имплантации искусственного хрусталика
IT1248669B (it) Derivato di idrossiprolina, sua preparazione e composizioni farmaceutiche che lo contengono
RU94023138A (ru) Способ реконструкции ампутационных культей голени